{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:23:06Z","timestamp":1795062186348,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673364"],"award-info":[{"award-number":["81673364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972894"],"award-info":[{"award-number":["81972894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2017ZX09101001006"],"award-info":[{"award-number":["2017ZX09101001006"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2017ZX09101001006"],"award-info":[{"award-number":["2017ZX09101001006"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Basic Research Plan of China"},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>One of the main challenges for immune checkpoint blockade antibodies lies in malignancies with limited T-cell responses or immunologically \u201ccold\u201d tumors. Inspired by the capability of fever-like heat in inducing an immune-favorable tumor microenvironment, mild photothermal therapy (PTT) is proposed to sensitize tumors to immune checkpoint inhibition and turn \u201ccold\u201d tumors \u201chot.\u201d Here we present a combined all-in-one and all-in-control strategy to realize a local symbiotic mild photothermal-assisted immunotherapy (SMPAI). We load both a near-infrared (NIR) photothermal agent IR820 and a programmed death-ligand 1 antibody (aPD-L1) into a lipid gel depot with a favorable property of thermally reversible gel-to-sol phase transition. Manually controlled NIR irradiation regulates the release of aPD-L1 and, more importantly, increases the recruitment of tumor-infiltrating lymphocytes and boosts T-cell activity against tumors. In vivo antitumor studies on 4T1 and B16F10 models demonstrate that SMPAI is an effective and promising strategy for treating \u201ccold\u201d tumors.<\/jats:p>","DOI":"10.1038\/s41467-019-12771-9","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T14:52:58Z","timestamp":1572015178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":563,"title":["Mild\u00a0photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy"],"prefix":"10.1038","volume":"10","author":[{"given":"Liping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunai","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9274-1866","authenticated-orcid":false,"given":"Liang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6588-6047","authenticated-orcid":false,"given":"Chunmeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"12771_CR1","doi-asserted-by":"publisher","first-page":"1707249","DOI":"10.1002\/adfm.201707249","volume":"28","author":"L Dai","year":"2018","unstructured":"Dai, L. et al. Size\/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration. Adv. Funct. Mater. 28, 1707249 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"12771_CR2","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai, Y. et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl Acad. Sci. USA 99, 12293\u201312297 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12771_CR3","doi-asserted-by":"publisher","first-page":"e1707112","DOI":"10.1002\/adma.201707112","volume":"30","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. PD-1 blockade cellular vesicles for cancer immunotherapy. Adv. Mater. 30, e1707112 (2018).","journal-title":"Adv. Mater."},{"key":"12771_CR4","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1021\/acsomega.8b00227","volume":"3","author":"R Patel","year":"2018","unstructured":"Patel, R., Czapar, A. E., Fiering, S., Oleinick, N. L. & Steinmetz, N. F. Radiation therapy combined with cowpea mosaic virus nanoparticle in situ vaccination initiates immune-mediated tumor regression. ACS Omega 3, 3702\u20133707 (2018).","journal-title":"ACS Omega"},{"key":"12771_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.trecan.2017.11.005","volume":"4","author":"GC Prendergast","year":"2018","unstructured":"Prendergast, G. C., Mondal, A., Dey, S., Laury-Kleintop, L. D. & Muller, A. J. Inflammatory reprogramming with IDO1 inhibitors: turning immunologically unresponsive \u2018cold\u2019 tumors \u2018hot\u2019. Trends Cancer 4, 38\u201358 (2018).","journal-title":"Trends Cancer"},{"key":"12771_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03900-x","volume":"9","author":"JF Anker","year":"2018","unstructured":"Anker, J. F. et al. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat. Commun. 9, 1591 (2018).","journal-title":"Nat. Commun."},{"key":"12771_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14572","volume":"8","author":"J Lau","year":"2017","unstructured":"Lau, J. et al. Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice. Nat. Commun. 8, 14572 (2017).","journal-title":"Nat. Commun."},{"key":"12771_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1172\/JCI96113","volume":"128","author":"H Lin","year":"2018","unstructured":"Lin, H. et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. J. Clin. Investig. 128, 805 (2018).","journal-title":"J. Clin. Investig."},{"key":"12771_CR9","doi-asserted-by":"publisher","first-page":"e1442168","DOI":"10.1080\/2162402X.2018.1442168","volume":"7","author":"KR Patel","year":"2018","unstructured":"Patel, K. R. et al. Increase in PD-L1 expression after pre-operative radiotherapy for soft tissue sarcoma. Oncoimmunology 7, e1442168 (2018).","journal-title":"Oncoimmunology"},{"key":"12771_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","volume":"175","author":"MF Sanmamed","year":"2018","unstructured":"Sanmamed, M. F. & Chen, L. A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell 175, 313\u2013326 (2018).","journal-title":"Cell"},{"key":"12771_CR11","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.7150\/thno.21471","volume":"7","author":"YP Chen","year":"2017","unstructured":"Chen, Y. P. et al. Genomic analysis of tumor microenvironment immune types across 14 solid cancer types: immunotherapeutic implications. Theranostics 7, 3585\u20133594 (2017).","journal-title":"Theranostics"},{"key":"12771_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","volume":"25","author":"W Scheper","year":"2019","unstructured":"Scheper, W. et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89\u201394 (2019).","journal-title":"Nat. Med."},{"key":"12771_CR13","doi-asserted-by":"publisher","first-page":"e1800424","DOI":"10.1002\/adhm.201800424","volume":"7","author":"Q Chen","year":"2018","unstructured":"Chen, Q., Wang, C., Chen, G., Hu, Q. & Gu, Z. Delivery strategies for immune checkpoint blockade. Adv. Healthc. Mater. 7, e1800424 (2018).","journal-title":"Adv. Healthc. Mater."},{"key":"12771_CR14","doi-asserted-by":"publisher","first-page":"1802540","DOI":"10.1002\/adfm.201802540","volume":"28","author":"Q Fan","year":"2018","unstructured":"Fan, Q., Chen, Z., Wang, C. & Liu, Z. Toward biomaterials for enhancing immune checkpoint blockade therapy. Adv. Funct. Mater. 28, 1802540 (2018).","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"12771_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J\u00e9r\u00f4me Galon","year":"2019","unstructured":"Galon J., Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197\u2013218 (2019).","journal-title":"Nature Reviews Drug Discovery"},{"key":"12771_CR16","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1126\/scitranslmed.aan3682","volume":"10","author":"JW Chao Wang","year":"2018","unstructured":"Chao Wang, J. W. et al. In situ formed reactive oxygen species\u2013responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy. Sci. Transl. Med. 10, 3682 (2018).","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"12771_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/ajh.25154","volume":"93","author":"C\u00e9dric Rossi","year":"2018","unstructured":"Rossi C., et al. Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: a series from Lysa centers. Am. J. Hematol. 93 (2018).","journal-title":"American Journal of Hematology"},{"key":"12771_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09116-1","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Synergistic immuno photothermal nanotherapy (SYMPHONY) for the treatment of unresectable and metastatic cancers. Sci. Rep. 7, 8606 (2017).","journal-title":"Sci. Rep."},{"key":"12771_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.addr.2017.06.008","volume":"114","author":"AJ Moy","year":"2017","unstructured":"Moy, A. J. & Tunnell, J. W. Combinatorial immunotherapy and nanoparticle mediated hyperthermia. Adv. Drug Deliv. Rev. 114, 175\u2013183 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"12771_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41551-018-0262-6","volume":"2","author":"Y Chao","year":"2018","unstructured":"Chao, Y. et al. Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses. Nat. Biomed. Eng. 2, 611\u2013621 (2018).","journal-title":"Nat. Biomed. Eng."},{"issue":"28","key":"12771_CR21","doi-asserted-by":"publisher","first-page":"1801527","DOI":"10.1002\/adma.201801527","volume":"30","author":"Shuangjiang Yu","year":"2018","unstructured":"Yu S., et al. Injectable bioresponsive gel depot for enhanced immune checkpoint blockade. Adv. Mater. 30, e1801527 (2018).","journal-title":"Advanced Materials"},{"key":"12771_CR22","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1021\/acs.nanolett.5b05030","volume":"16","author":"C Wang","year":"2016","unstructured":"Wang, C., Ye, Y., Hochu, G. M., Sadeghifar, H. & Gu, Z. Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody. Nano Lett. 16, 2334\u20132340 (2016).","journal-title":"Nano Lett."},{"key":"12771_CR23","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1016\/j.biomaterials.2011.12.029","volume":"33","author":"F Zhou","year":"2012","unstructured":"Zhou, F. et al. Antitumor immunologically modified carbon nanotubes for photothermal therapy. Biomaterials 33, 3235\u20133242 (2012).","journal-title":"Biomaterials"},{"key":"12771_CR24","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1002\/adma.201402996","volume":"26","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv. Mater. 26, 8154\u20138162 (2014).","journal-title":"Adv. Mater."},{"key":"12771_CR25","doi-asserted-by":"publisher","first-page":"1700891","DOI":"10.1002\/advs.201700891","volume":"5","author":"J Peng","year":"2018","unstructured":"Peng, J. et al. Photosensitizer micelles together with IDO inhibitor enhance cancer photothermal therapy and immunotherapy. Adv. Sci. 5, 1700891 (2018).","journal-title":"Adv. Sci."},{"key":"12771_CR26","doi-asserted-by":"publisher","first-page":"1801122","DOI":"10.1002\/advs.201801122","volume":"6","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Efficient near infrared light triggered nitric oxide release nanocomposites for sensitizing mild photothermal therapy. Adv. Sci. 6, 1801122 (2019).","journal-title":"Adv. Sci."},{"key":"12771_CR27","doi-asserted-by":"crossref","unstructured":"Yang Y. et al. 1D coordination polymer nanofibers for low-temperature photothermal therapy. Adv. Mater. 29 (2017).","DOI":"10.1002\/adma.201703588"},{"key":"12771_CR28","doi-asserted-by":"publisher","first-page":"1700805","DOI":"10.1002\/advs.201700805","volume":"5","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Fever-inspired immunotherapy based on photothermal CpG nanotherapeutics: the critical role of mild heat in regulating tumor microenvironment. Adv. Sci. 5, 1700805 (2018).","journal-title":"Adv. Sci."},{"key":"12771_CR29","doi-asserted-by":"publisher","first-page":"E966","DOI":"10.1073\/pnas.1500712112","volume":"112","author":"I Sagiv-Barfi","year":"2015","unstructured":"Sagiv-Barfi, I. et al. Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK. Proc. Natl Acad. Sci. USA 112, E966\u2013E972 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12771_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity. Nature 523, 231\u2013235 (2015).","journal-title":"Nature"},{"key":"12771_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0169-409X(96)00491-7","volume":"25","author":"RC Roger","year":"1997","unstructured":"Roger, R. C. Solubilisation of hydrophilic drugs in oily formulations. Adv. Drug Deliv. Rev. 25, 59\u201369 (1997). New CJK.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"12771_CR32","doi-asserted-by":"publisher","first-page":"328rv324","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou, W., Wolchok, J. D. & Chen, L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 8, 328rv324\u2013328rv324 (2016).","journal-title":"Sci. Transl. Med."},{"key":"12771_CR33","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.4161\/cbt.8.15.9133","volume":"8","author":"JP Higgins","year":"2009","unstructured":"Higgins, J. P., Bernstein, M. B. & Hodge, J. W. Enhancing immune responses to tumor-associated antigens. Cancer Biol. Ther. 8, 1440\u20131449 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"12771_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.coi.2015.06.007","volume":"35","author":"Y Wen","year":"2015","unstructured":"Wen, Y. & Collier, J. H. Supramolecular peptide vaccines: tuning adaptive immunity. Curr. Opin. Immunol. 35, 73\u201379 (2015).","journal-title":"Curr. Opin. Immunol."},{"key":"12771_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jconrel.2018.09.010","volume":"288","author":"R Mahjub","year":"2018","unstructured":"Mahjub, R. et al. Recent advances in applying nanotechnologies for cancer immunotherapy. J. Control Release 288, 239\u2013263 (2018).","journal-title":"J. Control Release"},{"key":"12771_CR36","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.bbrc.2012.08.010","volume":"425","author":"T Doi","year":"2012","unstructured":"Doi, T. et al. IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine. Biochem. Biophys. Res. Commun. 425, 918\u2013923 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12771_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.immuni.2011.03.029","volume":"35","author":"D Haribhai","year":"2011","unstructured":"Haribhai, D. et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35, 109\u2013122 (2011).","journal-title":"Immunity"},{"key":"12771_CR38","doi-asserted-by":"publisher","first-page":"e0148474","DOI":"10.1371\/journal.pone.0148474","volume":"11","author":"A Schmidt","year":"2016","unstructured":"Schmidt, A., Eriksson, M., Shang, M. M., Weyd, H. & Tegner, J. Comparative analysis of protocols to induce human CD4+Foxp3+ regulatory T cells by combinations of IL-2, TGF-beta, retinoic acid, rapamycin and butyrate. PLoS ONE 11, e0148474 (2016).","journal-title":"PLoS ONE"},{"key":"12771_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1479-5876-12-151","volume":"12","author":"D Quandt","year":"2014","unstructured":"Quandt, D., Jasinski-Bergner, S., M\u00fcller, U., Schulze, B. & Seliger, B. Synergistic effects of IL-4 and TNF\u03b1 on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation. J. Transl. Med. 12, 151 (2014).","journal-title":"J. Transl. Med."},{"key":"12771_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13193","volume":"7","author":"Q Chen","year":"2016","unstructured":"Chen, Q. et al. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat. Commun. 7, 13193 (2016).","journal-title":"Nat. Commun."},{"key":"12771_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ni889","volume":"4","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225\u2013234 (2003).","journal-title":"Nat. Immunol."},{"key":"12771_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nri778","volume":"2","author":"SM Kaech","year":"2002","unstructured":"Kaech, S. M., E John, W. & Raft, A. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251\u2013262 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"12771_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nano.2013.07.007","volume":"10","author":"G Weder","year":"2014","unstructured":"Weder, G. et al. Increased plasticity of the stiffness of melanoma cells correlates with their acquisition of metastatic properties. Nanomedicine 10, 141\u2013148 (2014).","journal-title":"Nanomedicine"},{"key":"12771_CR44","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.nano.2018.01.015","volume":"14","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. Versatile redox-sensitive pullulan nanoparticles for enhanced liver targeting and efficient cancer therapy. Nanomedicine 14, 1005\u20131017 (2018).","journal-title":"Nanomedicine"},{"key":"12771_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.carbpol.2016.11.094","volume":"159","author":"L Huang","year":"2017","unstructured":"Huang, L. et al. Efficient delivery of paclitaxel into ASGPR over-expressed cancer cells using reversibly stabilized multifunctional pullulan nanoparticles. Carbohydr. Polym. 159, 178\u2013187 (2017).","journal-title":"Carbohydr. Polym."},{"key":"12771_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12247-014-9183-4","volume":"9","author":"Y Wen","year":"2014","unstructured":"Wen, Y. & Meng, W. S. Recent in vivo evidences of particle-based delivery of small-interfering RNA (siRNA) into solid tumors. J. Pharm. Innov. 9, 158\u2013173 (2014).","journal-title":"J. Pharm. Innov."},{"key":"12771_CR47","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1002\/anie.201710068","volume":"57","author":"B Li","year":"2018","unstructured":"Li, B. et al. Mitigation of inflammatory immune responses with hydrophilic nanoparticles. Angew. Chem. 57, 4527\u20134531 (2018).","journal-title":"Angew. Chem."},{"key":"12771_CR48","doi-asserted-by":"publisher","first-page":"E6129","DOI":"10.1073\/pnas.1505799112","volume":"112","author":"PF Zhang","year":"2015","unstructured":"Zhang, P. F. et al. Virus-mimetic nanovesicles as a versatile antigen-delivery system. Proc. Natl Acad. Sci. USA 112, E6129\u2013E6138 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12771_CR49","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1021\/am501489e","volume":"6","author":"M Wadsater","year":"2014","unstructured":"Wadsater, M., Barauskas, J., Nylander, T. & Tiberg, F. Formation of highly structured cubic micellar lipid nanoparticles of soy phosphatidylcholine and glycerol dioleate and their degradation by triacylglycerol lipase. ACS Appl. Mater. interfaces 6, 7063\u20137069 (2014).","journal-title":"ACS Appl. Mater. interfaces"},{"key":"12771_CR50","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960\u20131964 (2006).","journal-title":"Science"},{"key":"12771_CR51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568 (2014).","journal-title":"Nature"},{"key":"12771_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0002-9440(10)61680-X","volume":"159","author":"K Takahashi","year":"2001","unstructured":"Takahashi, K. et al. Morphological interactions of interdigitating dendritic cells with B and T cells in human mesenteric lymph nodes. Am. J. Pathol. 159, 131\u2013138 (2001).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12771-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12771-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12771-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T20:44:18Z","timestamp":1671223458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12771-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12771"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12771-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4871"}}